Free Trial

Petros Pharmaceuticals (PTPI) Short Interest Ratio & Short Volume

Petros Pharmaceuticals logo
$0.07 -0.02 (-19.65%)
Closing price 03/31/2025 04:00 PM Eastern
Extended Trading
$0.07 0.00 (0.00%)
As of 03/31/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Petros Pharmaceuticals Short Interest Data

Petros Pharmaceuticals (PTPI) has a short interest of 745,300 shares, representing 7.50% of the float (the number of shares available for trading by the public). This marks a 113.06% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 9.03 million shares to cover all short positions.

Current Short Interest
745,300 shares
Previous Short Interest
349,800 shares
Change Vs. Previous Month
+113.06%
Dollar Volume Sold Short
$62,903.32
Short Interest Ratio
0.1 Days to Cover
Last Record Date
March 15, 2025
Outstanding Shares
11,319,000 shares
Short Percent of Float
7.50%
Today's Trading Volume
12,332,212 shares
Average Trading Volume
9,031,276 shares
Today's Volume Vs. Average
137%
Short Selling Petros Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Petros Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

PTPI Short Interest Over Time

PTPI Days to Cover Over Time

PTPI Percentage of Float Shorted Over Time

Remove Ads

Petros Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/15/2025745,300 shares $62,903.32 +113.1%7.5%0.1 $0.08
2/28/2025349,800 shares $34,210.44 -83.3%3.5%0.1 $0.10
2/15/20252,100,000 shares $615,300.00 +187.3%21.1%0.4 $0.29
1/31/2025731,000 shares $204,460.70 +15.7%N/A0.4 $0.28
1/15/2025631,800 shares $189,540.00 -2.2%6.9%0.3 $0.30
12/31/2024646,200 shares $254,538.18 +139.6%7.1%0.3 $0.39
12/15/2024269,700 shares $88,947.06 +48.9%3.0%0.2 $0.33
11/30/2024181,100 shares $49,693.84 -9.7%2.0%0.9 $0.27
11/15/2024200,600 shares $51,955.40 +0.7%2.2%1.1 $0.26
10/31/2024199,200 shares $73,704.00 -27.2%2.2%1.2 $0.37
10/15/2024273,600 shares $83,393.28 -7.2%3.1%1.4 $0.30
9/30/2024294,900 shares $105,279.30 +25.4%3.4%1.3 $0.36
9/15/2024235,100 shares $85,650.93 -20.6%2.7%0.8 $0.36
8/31/2024295,900 shares $98,445.93 +13.5%3.5%0.8 $0.33
8/15/2024260,700 shares $86,969.52 -40.0%3.1%0.6 $0.33
7/31/2024434,200 shares $176,285.20 +69.9%7.1%1 $0.41
7/15/2024255,500 shares $115,997.00 -28.5%4.2%0.6 $0.45
6/30/2024357,200 shares $163,419.00 -23.7%5.8%1 $0.46
6/15/2024468,300 shares $194,578.65 +202.3%7.7%1 $0.42
5/31/2024154,900 shares $95,139.58 +82.9%2.5%0.3 $0.61
5/15/202484,700 shares $43,671.32 -37.0%1.4%0.1 $0.52
4/30/2024134,500 shares $88,299.25 +92.7%3.3%0.2 $0.66
4/15/202469,800 shares $54,660.38 -52.3%1.7%0.1 $0.78
3/31/2024146,200 shares $216,376.00 +65.4%3.6%0.1 $1.48
3/15/202488,400 shares $134,368.00 -72.1%6.8%0.1 $1.52
2/29/2024317,200 shares $545,584.00 +12.3%24.2%0.3 $1.72
2/15/2024282,400 shares $434,896.00 +16.5%21.9%0.3 $1.54
1/31/2024242,400 shares $293,304.00 +2,208.6%18.8%0.4 $1.21
1/15/202410,500 shares $13,807.50 -74.8%0.8%0 $1.32
12/31/202341,700 shares $58,797.00 -66.5%3.1%0.2 $1.41
12/15/2023124,300 shares $172,777.00 +571.9%9.1%0.6 $1.39
11/30/202318,500 shares $29,600.00 -28.3%1.4%0.2 $1.60
11/15/202325,800 shares $34,314.00 -41.6%2.0%0.8 $1.33
10/31/202344,200 shares $63,206.00 -27.9%3.5%1.3 $1.43
10/15/202361,300 shares $98,073.87 +415.1%4.9%1.4 $1.60
9/30/202311,900 shares $20,585.81 +213.2%0.9%0 $1.73
9/15/20233,800 shares $6,878.00 -82.3%0.3%0 $1.81
8/31/202321,500 shares $54,825.00 -62.7%1.7%0.1 $2.55
8/15/202357,700 shares $184,640.00 -21.9%3.9%0.2 $3.20
7/31/202373,900 shares $296,339.00 -79.4%5.0%0.2 $4.01
Crypto Genius: 12,000% in 12 months? [Here’s how] (Ad)

We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.

If I’m right about this (like I was before) a modest $900 investment…
7/15/2023359,100 shares $1.14 million +1,330.7%24.3%0.5 $3.19
6/30/202325,100 shares $50,953.00 -27.0%1.7%0 $2.03
6/15/202334,400 shares $89,784.00 -10.7%2.3%0 $2.61
5/31/202338,500 shares $89,705.00 -13.5%2.6%0 $2.33
5/15/202344,500 shares $186,900.00 -88.5%3.0%0 $4.20
4/30/2023385,300 shares $1.66 million +1,029.9%27.3%0.2 $4.30
4/15/202334,100 shares $156,519.00 -22.5%2.4%0 $4.59
3/31/202344,000 shares $61,380.00 +14.9%3.1%3.1 $1.40
3/15/202338,300 shares $56,684.00 +13.0%2.7%2.1 $1.48
2/28/202333,900 shares $71,190.00 -6.6%2.4%1.6 $2.10
2/15/202336,300 shares $92,202.00 +23.1%2.5%1.8 $2.54
1/31/202329,500 shares $76,700.00 -24.4%2.1%1.5 $2.60
1/15/202339,000 shares $118,950.00 +14.0%2.7%1.6 $3.05
12/30/202234,200 shares $79,686.00 +14.8%2.4%1.4 $2.33
12/15/202229,800 shares $63,176.00 +43.3%2.1%1.8 $2.12
11/30/202220,800 shares $8,550.88 -92.2%1.4%1.5 $0.41
11/15/2022265,700 shares $130,193.00 +78.6%N/A2.1 $0.49
10/31/2022148,800 shares $71,424.00 +9.3%N/A1 $0.48
10/15/2022136,200 shares $58,525.14 +77.3%N/A0.2 $0.43
9/30/202276,800 shares $39,168.00 -36.1%N/A0.1 $0.51
9/15/2022120,200 shares $78,682.92 -7.1%N/A0.1 $0.65
8/31/2022129,400 shares $84,821.70 +45.4%N/A0.1 $0.66
8/15/202289,000 shares $71,627.20 +420.5%N/A0.1 $0.80
7/31/202217,100 shares $13,573.98 -22.3%N/A0 $0.79
7/15/202222,000 shares $18,099.40 -56.2%N/A0.1 $0.82
6/30/202250,200 shares $42,157.96 +46.8%N/A0 $0.84
6/15/202234,200 shares $26,744.40 -81.0%N/A0 $0.78
5/31/2022179,500 shares $174,976.60 +89.2%N/A0.1 $0.97
5/15/202294,900 shares $91,113.49 -30.0%N/A0.1 $0.96
4/30/2022135,600 shares $153,228.00 -26.0%N/A0.1 $1.13
4/15/2022183,300 shares $221,793.00 -39.8%N/A0.1 $1.21
3/31/2022304,400 shares $474,864.00 +15.1%N/A0.4 $1.56
3/15/2022264,500 shares $285,660.00 -39.7%N/A0.1 $1.08
2/28/2022438,900 shares $605,682.00 -38.5%N/A0.1 $1.38
2/15/2022714,000 shares $1.14 million -15.3%N/A0.1 $1.59
1/31/2022842,700 shares $1.46 million -54.9%N/A0.1 $1.73
1/15/20221,870,000 shares $4.90 million -19.7%N/A0.1 $2.62
12/31/20212,330,000 shares $7.76 million -22.9%28.1%0.1 $3.33
12/15/20213,020,000 shares $8.67 million +41.1%35.7%0.2 $2.87
11/30/20212,140,000 shares $6.12 million +459.6%55.9%0.2 $2.86
11/15/2021382,400 shares $833,632.00 +359.6%8.9%0.1 $2.18
10/29/202183,200 shares $144,768.00 -22.2%2.6%0 $1.74
10/15/2021106,900 shares $175,316.00 +20.0%1.8%1.2 $1.64
9/30/202189,100 shares $178,200.00 -22.9%1.5%1.6 $2.00
9/15/2021115,600 shares $239,292.00 -20.8%1.9%2.1 $2.07
8/31/2021145,900 shares $328,275.00 -16.1%2.4%1.8 $2.25
8/13/2021173,900 shares $525,178.00 -9.1%2.8%1.7 $3.02
7/30/2021191,200 shares $581,248.00 +19.3%3.1%0.9 $3.04
7/15/2021160,300 shares $488,915.00 +18.3%2.6%0.8 $3.05
6/30/2021135,500 shares $424,115.00 +21.1%2.2%0.7 $3.13
Crypto Genius: 12,000% in 12 months? [Here’s how] (Ad)

We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.

If I’m right about this (like I was before) a modest $900 investment…
6/15/2021111,900 shares $349,128.00 +105.0%1.8%0.5 $3.12
5/28/202154,600 shares $165,438.00 -1.1%0.9%0.3 $3.03
5/14/202155,200 shares $162,840.00 -18.9%0.9%0.3 $2.95
4/30/202168,100 shares $224,730.00 +6.2%1.1%1.4 $3.30
4/15/202164,100 shares $201,915.00 -19.0%1.0%0.8 $3.15
3/31/202179,100 shares $288,715.00 +4.2%1.3%0.9 $3.65
3/15/202175,900 shares $256,542.00 +20.5%1.2%0.5 $3.38
2/26/202163,000 shares $218,610.00 -9.1%1.0%0.4 $3.47
2/12/202169,300 shares $293,832.00 +234.8%1.1%0.4 $4.24
1/29/202120,700 shares $70,173.00 +269.6%0.3%0.1 $3.39
1/15/20215,600 shares $24,136.00 No ChangeN/A0 $4.31

PTPI Short Interest - Frequently Asked Questions

What is Petros Pharmaceuticals' current short interest?

Short interest is the volume of Petros Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of March 15th, traders have sold 745,300 shares of PTPI short. 7.50% of Petros Pharmaceuticals' shares are currently sold short. Learn More on Petros Pharmaceuticals' current short interest.

Which institutional investors are shorting Petros Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Petros Pharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Petros Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.50% of Petros Pharmaceuticals' floating shares are currently sold short.

Is Petros Pharmaceuticals' short interest increasing or decreasing?

Petros Pharmaceuticals saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 745,300 shares, an increase of 113.1% from the previous total of 349,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Petros Pharmaceuticals' short interest compare to its competitors?

7.50% of Petros Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Petros Pharmaceuticals: Conduit Pharmaceuticals Inc. (105.83%), Genprex, Inc. (4.03%), Lipella Pharmaceuticals Inc. (2.94%), Upexi, Inc. (3.82%), Tharimmune, Inc. (1.59%), Psyence Biomedical Ltd. (28.27%), Matinas Biopharma Holdings, Inc. (0.66%), Lixte Biotechnology Holdings, Inc. (2.87%), Scinai Immunotherapeutics Ltd. (1.11%), CERo Therapeutics Holdings, Inc. (34.57%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks.

What does it mean to sell short Petros Pharmaceuticals stock?

Short selling PTPI is an investing strategy that aims to generate trading profit from Petros Pharmaceuticals as its price is falling. PTPI shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Petros Pharmaceuticals?

A short squeeze for Petros Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PTPI, which in turn drives the price of the stock up even further.

How often is Petros Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PTPI, twice per month. The most recent reporting period available is March, 15 2025.




This page (NASDAQ:PTPI) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners